This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Liver
CD2_BENIGN_LIVER_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum hepatis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Liver
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Liver
- Benign neoplasm: Liver/bile ducts
- Benign neoplasm: Liver/bile ducts
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 786 | 574 | 212 |
| Unadjusted period prevalence (%) | 0.17 | 0.20 | 0.09 |
| Median age at first event (years) | 52.28 | 48.71 | 61.94 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 677
- Matched controls
- 6769
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.4
ICD-10 Finland
Benign neoplasm: Liver
+∞
323.0
666
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
149.2
155.0
160
14
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
36.6
106.9
138
47
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
38.4
77.8
99
30
130
Kela drug reimbursment
Malignant tumour
+∞
58.2
55
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
30.4
56.6
76
28
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.8
53.3
147
266
H02AB02
ATC
dexamethasone; systemic
19.3
37.3
57
32
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
60.6
34.6
40
7
PJA12
NOMESCO Finland
Sentinel node biopsy
331.9
32.1
32
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
29.2
314
1695
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.6
28.7
108
270
115
Kela drug reimbursment
Breast cancer
+∞
28.3
27
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
9.8
28.3
58
64
C61
ICD-10 Finland
Malignant neoplasm of prostate
281.7
26.9
27
*
A04AA02
ATC
granisetron; systemic, transdermal
100.9
26.9
29
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
25.2
24
*
JN4BD
NOMESCO Finland
Extensive body CT
6.7
25.1
66
108
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
24.5
228
1108
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.9
23.0
165
683
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
22.8
123
416
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
15.3
21.4
35
24
UJF32
NOMESCO Finland
Coloscopy
2.6
21.1
193
914
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
20.9
20
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
20.9
20
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
113.5
20.7
22
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.5
20.4
42
47
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
20.0
132
513
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
56.7
19.0
22
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
18.8
18
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
18.8
18
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
102.9
18.7
20
*
D18.0
ICD-10 Finland
Haemangioma, any site
8.7
18.2
39
47
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
17.8
17
*
JN4CD
NOMESCO Finland
Very extensive body CT
11.9
17.7
32
28
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
16.9
209
1135
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
16.7
16
*
K76.89
ICD-10 Finland
Other specified diseases of liver
30.9
16.2
21
7
B01AB05
ATC
enoxaparin; parenteral
2.2
16.1
188
990
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
12.6
16.0
28
23
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
15.9
183
956
A02BC02
ATC
pantoprazole; systemic
2.0
15.9
435
3223
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
61.5
15.8
18
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
15.7
15
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
15.7
15
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
15.7
15
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
15.7
15
*
L01BC06
ATC
capecitabine; oral
+∞
15.7
15
*
L03AA13
ATC
pegfilgrastim; parenteral
163.6
15.5
16
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
20.6
15.2
22
11
A04AA01
ATC
ondansetron; systemic, rectal
6.1
14.4
39
67
XX3DW
NOMESCO Finland
Time consuming IT work
4.5
14.3
51
120
Z51.5
ICD-10 Finland
Palliative care
10.4
14.1
27
27
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.1
12.9
18
8
J01MA02
ATC
ciprofloxacin; systemic
1.9
12.8
255
1637
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
12.5
12
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
+∞
12.5
12
*
HAC20
NOMESCO Finland
Total mastectomy
132.4
12.5
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
12.3
248
1595
N02AX02
ATC
tramadol; systemic, rectal
1.8
12.2
267
1766
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
11.8
133
678
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.7
11.7
29
45
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
11.6
181
1055
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
11.5
11
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
11.5
11
*
21150
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Hepatis
+∞
11.5
11
*
ZX120
NOMESCO Finland
Intravenous
3.2
11.5
60
198
N02BE01
ATC
paracetamol; systemic, rectal
2.0
11.4
568
4871
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.3
11.3
57
183
WF002
NOMESCO Finland
Radical radiotherapy
35.7
11.3
14
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
35.7
11.3
14
*
WX402
NOMESCO Finland
General anaesthesia
2.3
11.2
109
516
K76.80
ICD-10 Finland
Hepatic cyst
13.0
11.2
19
15
JN4AD
NOMESCO Finland
Body CT examination
5.1
11.1
34
69
L02BG04
ATC
letrozole; oral
6.3
10.9
28
46
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
10.5
39
97
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
7.9
10.5
23
30
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
111.7
10.4
11
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
111.7
10.4
11
*
A04AD12
ATC
aprepitant; systemic
111.7
10.4
11
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.4
10
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
10.4
10
*
116
Kela drug reimbursment
Prostate cancer
+∞
10.4
10
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
10.4
10
*
X76
ICPC
Malignant neoplasm breast female
+∞
10.4
10
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
10.4
92
416
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
33.1
10.4
13
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
23.8
10.3
14
6
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
10.0
135
739
UKC02
NOMESCO Finland
Cystoscopy
2.4
9.8
89
408
XKD00
NOMESCO Finland
Uroflowmetry
2.5
9.6
80
351
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
30.5
9.4
12
*
L02BA01
ATC
tamoxifen; oral
30.5
9.4
12
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
L03AA02
ATC
filgrastim; parenteral
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
9.4
9
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
9.4
9
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
9.4
9
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
9.4
9
*
R4110
NOMESCO Finland
Physiotherapy
1.9
9.4
158
941
A02BC05
ATC
esomeprazole; systemic
1.7
9.3
262
1835
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
3.8
9.3
38
104
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.2
9.0
46
150
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
8.9
154
921
ZX080
NOMESCO Finland
Image guided radiotherapy
50.7
8.7
10
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
8.6
73
324
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.9
8.6
53
195
P01AB01
ATC
metronidazole; oral, rectal
1.6
8.5
272
1961
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
91.2
8.4
9
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
8.3
8
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
8.3
8
*
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
8.3
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.3
8
*
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
+∞
8.3
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
8.3
53
201
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
8.2
174
1110
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
8.1
47
167
B01AB10
ATC
tinzaparin; parenteral
3.3
8.1
40
128
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
8.0
119
672
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
22.3
8.0
11
5
HA1AA
NOMESCO Finland
X-ray mammography
3.7
8.0
33
92
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
45.5
7.7
9
*
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
5.3
7.6
22
43
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
12.0
7.6
13
11
WX110
NOMESCO Finland
Local anesthesy
1.6
7.6
443
3678
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
7.6
142
869
NK6AN
NOMESCO Finland
Total body bone isotope imaging
25.3
7.6
10
*
N02AA05
ATC
oxycodone; systemic
2.4
7.5
61
265
A02BC01
ATC
omeprazole; systemic
1.7
7.5
174
1138
J01DB01
ATC
cefalexin; oral
1.7
7.4
534
4666
ZX090
NOMESCO Finland
Other technic of radiotherapy
80.9
7.4
8
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.1
7.4
86
443
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
4.3
7.4
26
63
J01MA12
ATC
levofloxacin; systemic
2.0
7.4
103
568
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
7.3
7
*
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
+∞
7.3
7
*
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
15.9
7.2
11
7
JAH00
NOMESCO Finland
Laparotomy
4.5
7.2
24
55
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.3
7.1
33
102
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
6.9
100
560
A02BC03
ATC
lansoprazole; oral
1.6
6.9
188
1285
WX704
NOMESCO Finland
Intubation
2.7
6.9
44
168
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.2
6.8
17
28
R06.0
ICD-10 Finland
Dyspnoea
1.7
6.8
153
989
JJA20
NOMESCO Finland
Open biopsy of liver
40.5
6.8
8
*
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
3.4
6.6
30
91
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
6.6
200
1402
R51.80
ICD-10 Finland
Headache
1.8
6.5
107
627
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.3
6.5
57
258
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.5
6.5
28
82
Z51.0
ICD-10 Finland
Radiotherapy session
70.5
6.4
7
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
14.5
6.4
10
7
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
6.4
235
1724
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.3
6
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
7.1
6.2
14
20
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
26.9
6.2
8
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
26.9
6.2
8
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.4
6.2
50
218
WZC30
NOMESCO Finland
Teaching
2.2
6.1
64
313
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.3
6.1
52
233
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
5.0
6.1
18
37
ZXA00
NOMESCO Finland
Right side
1.7
6.1
144
944
N03AX16
ATC
pregabalin; oral
1.7
6.1
141
919
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
251
243
14.71
240.05
2.5
1.5
2.6
2.8
ug/l
0.31
170
184
146
52
34.25
222.38
1.8
1.8
3.5
81.9
u/ml
0.49
146
47
154
96
19.71
186.65
2.2
1.9
11.0
133.7
u/ml
0.80
136
75
584
2801
5.22
98.44
6.8
3.5
10.4
10.8
umol/l
0.45
561
2637
194
417
5.85
89.47
2.4
2.1
0.2
0.2
g/l
1.80
187
385
220
605
4.66
74.88
3.9
2.1
5.2
5.6
umol/l
0.44
194
514
462
2293
3.46
63.67
5.6
3.5
36.2
36.5
g/l
0.41
438
2135
684
4601
4.75
54.02
9.4
5.1
79.3
73.2
u/l
4.61
659
4280
355
1868
2.64
38.17
3.2
2.2
56.7
56.1
u/l
0.08
327
1731
374
2061
2.55
35.97
4.2
2.5
30.5
29.0
u/l
0.57
361
1970
269
1283
2.67
34.69
2.4
1.9
—
—
—
0
0
442
2716
2.43
32.43
4.0
3.5
—
—
—
0
0
508
3399
2.40
29.63
6.1
4.0
6.6
6.5
mmol/l
0.20
487
3108
499
3375
2.31
27.45
8.7
6.5
4.4
4.1
e9/l
1.91
432
2959
385
2344
2.26
27.32
7.8
4.9
1.2
1.2
mmol/l
0.03
355
2101
414
2637
2.20
25.79
8.6
5.3
1.2
1.2
mmol/l
0.03
371
2255
111
389
3.16
24.72
8.0
6.8
7.7
9.4
mmol/l
1.44
105
369
158
684
2.64
23.77
3.1
2.2
23.9
24.0
%
0.04
145
582
168
767
2.51
22.55
2.9
2.1
2.5
2.4
g/l
1.09
157
712
176
848
2.39
20.85
3.0
2.1
14.2
14.0
umol/l
0.12
167
776
583
4448
2.20
20.64
4.4
2.8
60.2
39.5
u/l
7.63
561
4203
133
571
2.60
20.14
9.7
6.7
105.1
104.4
mmol/l
1.31
133
561
120
504
2.63
18.94
3.1
2.1
31.4
35.6
u/l
0.49
98
422
744
6474
3.79
17.85
16.8
10.3
23.7
20.4
mg/l
1.71
643
4925
534
4047
2.00
17.76
5.0
3.9
439.7
2297.6
e6/l
—
6
53
600
4749
2.11
17.56
4.3
3.9
11.8
10.6
mm/h
1.30
561
4410
138
651
2.36
16.89
6.1
4.7
1.0
1.0
mmol/l
0.09
126
594
105
437
2.62
16.81
4.3
3.2
226.2
235.4
u/l
0.41
100
413
743
6560
3.42
15.32
18.5
11.7
139.6
139.7
mmol/l
0.19
734
6375
152
781
2.17
15.05
3.7
2.5
0.8
0.8
mmol/l
0.51
138
723
743
6578
3.37
14.88
18.6
11.7
3.9
3.9
mmol/l
1.63
733
6378
95
401
2.56
14.72
3.8
3.7
77.7
81.9
ng/l
0.24
79
365
257
1610
1.89
14.52
3.7
2.8
54.8
101.7
e6/l
0.44
186
1211
238
1456
1.91
14.45
3.4
2.7
0.3
0.4
e6/l
0.39
164
1063
153
808
2.11
14.05
3.4
2.6
3.1
3.1
e6/l
0.03
80
412
277
1795
1.84
13.95
3.0
2.0
2.4
2.3
mmol/l
1.41
242
1523
113
539
2.28
13.33
9.3
7.5
5.2
5.1
kpa
0.44
113
518
158
868
2.03
12.96
2.7
2.4
0.9
1.0
e6/l
0.11
82
471
111
533
2.26
12.87
9.1
7.5
0.4
1.4
mmol/l
1.91
94
407
228
1434
1.83
12.39
2.2
1.7
1.1
0.9
mg/l
0.35
179
1061
151
834
2.00
12.15
2.0
1.7
1.4
1.4
%
0.13
136
752
31
74
4.32
12.08
1.3
1.4
—
—
—
0
0
151
836
2.00
12.06
2.0
2.4
124.8
104.1
ug/g
0.37
116
655
241
1561
1.78
11.79
1.4
1.3
0.6
2.0
u/ml
2.78
72
457
22
46
4.89
10.06
1.4
1.2
39.5
53.3
u/l
1.27
15
32
226
1506
1.70
9.70
2.4
2.1
2.7
2.8
mg/l
0.27
193
1281
30
86
3.59
9.15
1.2
1.2
—
—
—
0
0
89
452
2.09
8.90
2.9
2.0
80.6
72.5
ml/min/173m2
0.92
37
177
42
151
2.88
8.88
1.5
1.4
290.2
317.5
ug/g
0.32
22
86
71
330
2.27
8.86
1.5
1.6
—
—
—
0
0
222
1503
1.66
8.85
3.0
2.2
1456.1
5083.8
umol/l
1.61
197
1309
297
2170
1.59
8.66
3.2
3.2
26.5
56.5
ng/l
0.86
176
1288
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
35
115
3.14
8.65
4.3
2.6
0.3
0.4
u/ml
1.69
16
57
20
45
4.53
8.40
1.5
1.2
—
—
—
0
0
152
945
1.75
8.23
2.9
1.9
2.5
2.4
mmol/l
3.22
137
814
166
1065
1.71
8.02
3.4
3.3
1651.3
308.7
ng/l
0.46
112
738
342
2616
1.54
7.98
2.9
2.3
73.1
76.4
nmol/l
1.47
312
2369
746
6944
2.46
7.51
13.5
8.1
28.6
25.3
u/l
4.72
731
6713
111
645
1.84
7.50
26.6
22.2
1.3
1.3
inr
—
10
89
673
6064
1.76
7.21
14.8
9.0
86.9
85.2
ml/min/173m2
1.22
567
4853
119
725
1.76
6.85
8.3
5.7
—
—
—
0
0
388
3118
1.48
6.79
5.2
4.4
0.0
0.0
estimate
0.50
56
559
55
260
2.20
6.62
2.0
2.2
42.1
40.5
u/l
0.27
50
235
49
221
2.30
6.59
1.7
1.8
—
—
—
0
0
391
3166
1.47
6.48
3.9
3.2
0.0
0.0
estimate
0.50
53
542
386
3122
1.46
6.41
4.0
3.2
0.0
0.0
estimate
0.00
53
558
385
3114
1.46
6.38
3.9
2.7
112.4
93.4
ug/l
1.06
365
2923
34
132
2.65
6.28
2.6
3.4
—
—
—
0
0
197
1393
1.55
6.28
1.7
1.6
—
—
—
0
0
15
35
4.35
6.04
4.0
1.1
11.1
54.1
u/ml
—
5
9
18
49
3.74
5.95
1.3
1.3
—
—
—
0
0
26
90
2.95
5.94
1.0
1.0
0.1
0.1
u/ml
—
8
21
308
2422
1.45
5.74
2.1
1.9
101.2
97.4
pmol/l
0.62
175
1279
34
139
2.51
5.69
1.1
1.1
0.8
2.4
u/ml
0.80
12
53
11
21
5.30
5.53
1.1
1.3
16.1
15.8
ug/l
0.03
11
21
18
52
3.52
5.48
1.2
1.0
—
—
—
0
0
16
43
3.78
5.39
1.4
1.4
—
—
—
0
0
197
1435
1.50
5.38
2.8
2.8
1348.8
969.2
ng/l
0.49
167
1198
67
373
1.87
5.19
1.1
1.0
—
—
—
0
0
79
464
1.78
5.15
1.2
1.3
116.6
224.2
u/ml
1.18
72
429
90
551
1.72
5.08
1.7
1.7
—
—
—
0
0
89
550
1.70
4.86
1.6
1.7
—
—
—
0
0
34
150
2.32
4.86
6.2
4.1
3.8
3.8
mmol/l
0.25
34
141
120
801
1.59
4.84
1.8
1.7
—
—
—
0
0
41
197
2.14
4.79
1.3
1.3
—
—
—
0
0
7
5
14.11
4.58
2.9
1.0
13.3
16.0
u/ml
—
7
5
75
450
1.74
4.56
2.0
2.4
7.7
6.6
ug/l
0.17
66
395
28
118
2.42
4.44
1.0
1.1
0.4
2.0
u/ml
0.90
11
28
26
107
2.48
4.34
1.0
1.0
1.5
2.9
u/ml
0.64
13
36
57
320
1.84
4.33
1.4
1.5
—
—
—
0
0
15
46
3.30
4.20
2.3
1.8
—
—
—
0
0
38
188
2.07
4.15
2.1
1.9
1.5
1.4
g/l
0.15
32
164
226
1764
1.39
4.13
2.1
2.1
152.5
195.9
u/l
0.43
213
1666
583
5281
1.40
4.12
4.8
4.1
14.6
14.5
pmol/l
0.14
538
4885
33
155
2.18
4.11
1.8
1.8
5.3
1.5
ug/l
0.43
26
140
37
183
2.07
4.05
5.9
3.7
1.1
1.4
mmol/l
1.20
37
178
49
268
1.88
4.05
1.6
1.6
—
—
—
0
0
54
305
1.83
4.04
3.5
2.1
12.3
12.9
nmol/l
0.19
45
271
28
125
2.29
3.94
1.2
1.2
—
—
—
0
0
69
429
1.67
3.72
3.2
3.2
4.4
4.6
pmol/l
0.81
62
376
24
103
2.37
3.70
1.2
1.1
—
—
—
0
0
180
1376
1.40
3.67
1.6
1.5
19.2
21.3
nmol/l
1.24
152
1195
25
110
2.31
3.65
1.6
1.2
2.0
9.0
u/ml
1.27
12
39
138
1007
1.45
3.64
1.7
1.7
1127.8
1208.6
nmol/l
0.51
108
762
600
5505
1.38
3.59
21.0
12.4
13.7
13.5
%
0.96
595
5382
11
31
3.58
3.49
1.2
1.0
—
—
—
0
0
88
594
1.54
3.40
2.0
1.8
409.6
369.1
nmol/l
0.87
74
545
663
6205
1.44
3.38
5.8
4.7
1.7
2.0
mu/l
0.99
621
5770
23
102
2.29
3.32
1.6
1.2
1.4
3.8
u/ml
—
8
33
69
446
1.60
3.21
4.6
3.2
2.2
2.1
mmol/l
0.03
57
350
40
222
1.84
3.21
1.8
1.5
1.3
1.2
g/l
0.79
40
208
10
28
3.60
3.20
1.5
1.4
—
—
—
0
0
60
384
1.61
2.93
2.2
1.6
66.4
67.9
g/l
0.86
53
343
225
1843
1.31
2.86
3.6
3.0
7.7
7.6
mmol/l
0.02
199
1571
89
627
1.47
2.83
1.8
1.8
—
—
—
0
0
8
18
4.48
2.80
1.5
1.2
—
—
—
0
0
7
14
5.03
2.73
1.0
1.1
92.7
108.1
%
—
7
14
7
14
5.03
2.73
1.0
1.1
—
—
—
0
0
759
7367
1.88
2.73
26.3
15.6
134.5
135.8
g/l
2.15
752
7266
14
54
2.62
2.71
1.1
1.1
—
—
—
0
0
287
2444
1.27
2.68
4.3
3.2
—
—
—
0
0
177
1423
1.31
2.56
1.6
1.4
—
—
—
0
0
17
75
2.29
2.52
1.3
1.2
—
—
—
0
0
17
75
2.29
2.52
1.3
1.2
—
—
—
0
0
17
75
2.29
2.52
1.3
1.2
—
—
—
0
0
8
21
3.84
2.46
3.5
2.1
—
—
—
0
0
632
5951
1.32
2.43
6.5
5.2
39.8
39.1
mmol/mol
1.03
598
5587
37
221
1.71
2.38
6.0
3.2
24.6
24.4
mmol/l
0.17
32
194
159
1272
1.31
2.37
1.3
1.3
28.1
32.3
iu/ml
0.18
44
409
173
1401
1.30
2.36
4.8
3.4
1.0
1.0
kg/l
0.61
21
197
17
78
2.21
2.32
1.3
1.2
—
—
—
0
0
17
78
2.21
2.32
1.3
1.2
—
—
—
0
0
17
78
2.21
2.32
1.3
1.2
—
—
—
0
0
16
72
2.25
2.29
1.4
1.5
—
—
—
0
0
21
106
2.01
2.27
1.5
1.5
—
—
—
0
0
7
18
3.91
2.25
1.0
1.1
—
—
—
0
0
5
9
5.58
2.21
1.6
1.8
—
—
—
0
0
30
173
1.76
2.20
2.7
1.4
2.8
3.0
g/l
1.36
23
133
12
48
2.52
2.19
1.6
1.3
—
—
—
0
0
6
165
0.36
2.17
1.7
1.5
—
—
—
0
0
52
349
1.52
2.13
1.7
2.1
5712.2
3517.1
u/l
0.25
15
150
39
245
1.62
2.11
1.9
1.7
—
—
—
0
0
69
493
1.44
2.08
1.7
1.7
—
—
—
0
0
211
1778
1.26
2.08
4.5
3.9
16.3
8.7
mg/mmol
0.71
150
1111
34
208
1.66
2.04
2.7
4.3
1.7
1.6
%
0.18
34
197
150
1216
1.29
2.03
1.3
1.3
19.3
12.0
u/ml
0.41
66
479
21
111
1.92
2.02
1.4
1.5
—
—
—
0
0
8
26
3.10
2.01
1.1
1.2
—
—
—
0
0
64
455
1.44
1.99
1.4
1.3
24.7
28.1
iu/l
0.38
54
395
194
1628
1.25
1.98
4.8
3.4
0.0
0.0
estimate
0.88
54
555
6
16
3.77
1.93
1.3
1.3
—
—
—
0
0
6
16
3.77
1.93
3.0
2.0
59.2
45.6
ug/l
—
6
16
6
16
3.77
1.93
1.3
1.3
—
—
—
0
0
6
16
3.77
1.93
1.3
1.3
—
—
—
0
0
659
6292
1.29
1.91
4.3
3.7
1.4
1.3
mmol/l
5.24
614
5843
14
65
2.17
1.89
1.4
1.4
—
—
—
0
0
684
6569
1.32
1.85
4.8
4.1
4.7
4.8
mmol/l
0.46
647
6172
30
183
1.66
1.84
2.7
1.3
6.7
7.4
g/l
1.79
23
139
30
183
1.66
1.84
2.7
1.3
—
—
—
0
0
30
183
1.66
1.84
2.7
1.3
3.7
3.8
g/l
0.17
23
131
7
23
3.06
1.80
1.1
1.2
—
—
—
0
0
201
1715
1.23
1.75
1.7
1.7
1.6
1.4
mmol/l
2.57
184
1477
97
757
1.32
1.74
4.4
4.3
31.3
32.0
%
0.23
64
526
12
54
2.24
1.74
1.1
1.2
—
—
—
0
0
33
210
1.60
1.73
1.5
1.6
0.1
0.1
iu/ml
—
10
34
680
6539
1.30
1.72
4.7
4.1
1.5
1.5
mmol/l
1.73
637
6121
12
55
2.20
1.68
1.1
1.2
—
—
—
0
0
16
83
1.95
1.65
1.9
1.5
—
—
—
0
0
506
4726
1.20
1.65
3.7
3.4
—
—
—
0
0
60
438
1.40
1.65
1.3
1.3
—
42.5
—
0
22
644
6161
1.25
1.64
20.1
11.4
39.8
40.1
%
0.34
500
4694
27
166
1.65
1.63
2.9
1.3
9.9
10.5
g/l
0.37
22
142
5
14
3.59
1.61
1.2
2.1
—
—
—
0
0
10
43
2.34
1.60
1.3
1.2
—
—
—
0
0
10
43
2.34
1.60
1.3
1.2
—
—
—
0
0
10
43
2.34
1.60
1.3
1.2
—
—
—
0
0
92
722
1.31
1.60
3.1
2.5
0.9
0.7
ug/l
0.65
64
468
22
129
1.73
1.58
1.4
1.2
—
—
—
0
0
45
316
1.45
1.54
3.1
3.1
1.3
1.7
mmol/l
0.31
36
237
8
33
2.44
1.54
1.5
2.3
4819.0
666.0
u/ml
—
8
33
47
334
1.43
1.51
3.1
3.1
5.2
5.1
kpa
0.07
40
314
16
86
1.88
1.51
1.0
1.1
—
—
—
0
0
30
194
1.57
1.50
1.5
1.3
—
—
—
0
0
34
228
1.51
1.46
2.9
3.4
41.4
47.6
%
0.87
34
223
123
1016
1.25
1.44
4.3
3.6
21.3
24.1
%
1.62
71
464
17
95
1.81
1.44
1.6
1.3
93.5
119.3
u/ml
—
5
21
6
22
2.74
1.43
1.7
1.6
—
—
—
0
0
6
22
2.74
1.43
1.7
1.6
—
—
—
0
0
149
1262
1.22
1.39
5.5
3.7
2.8
2.0
ug/l
1.54
138
1130
11
53
2.09
1.39
2.7
4.0
—
—
—
0
0
9
42
2.16
1.34
1.9
1.5
—
—
—
0
0
16
90
1.79
1.34
1.1
1.4
—
—
—
0
0
16
90
1.79
1.34
1.1
1.4
—
—
—
0
0
16
90
1.79
1.34
1.3
1.4
—
—
—
0
0
12
61
1.98
1.33
1.6
1.5
—
—
—
0
0
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
659
6361
1.22
1.29
4.8
4.1
5.9
5.8
mmol/l
0.97
617
5891
29
194
1.51
1.28
1.4
1.2
1.6
2.8
u/ml
—
5
24
9
44
2.06
1.27
1.1
1.2
—
—
—
0
0
8
35
2.30
1.27
1.0
1.2
—
—
—
0
0
18
107
1.70
1.26
1.3
1.2
176.5
223.5
u/ml
—
8
65
687
6663
1.25
1.26
5.3
4.5
2.8
2.8
mmol/l
1.54
646
6242
45
330
1.39
1.25
1.5
1.5
—
—
—
0
0
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
6
25
2.41
1.24
1.0
1.1
0.3
0.3
g/l
—
6
19
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
29
198
1.48
1.18
1.4
1.2
5.1
10.6
u/ml
—
8
37
27
182
1.50
1.17
1.2
1.2
11.6
10.8
u/l
0.10
18
150
51
388
1.34
1.15
4.5
2.2
1.2
1.2
mmol/l
0.42
46
326
34
242
1.42
1.13
2.9
3.1
25.3
25.5
mmol/l
0.10
34
233
11
58
1.91
1.12
1.1
1.1
—
—
—
0
0
11
58
1.91
1.12
1.1
1.1
—
—
—
0
0
20
127
1.59
1.12
1.4
1.3
23.9
25.9
u/l
0.09
15
100
15
88
1.72
1.12
1.1
1.2
0.5
0.6
nmol/l
0.53
15
83
10
51
1.97
1.11
1.4
1.4
—
—
—
0
0
19
120
1.60
1.09
1.3
1.2
—
—
—
0
0
15
89
1.70
1.08
1.1
1.2
—
0.7
nmol/l
—
0
7
11
59
1.88
1.07
1.1
1.1
—
—
—
0
0
11
59
1.88
1.07
1.1
1.1
—
—
—
0
0
11
59
1.88
1.07
1.1
1.1
—
—
—
0
0
7
33
2.13
1.05
2.1
1.6
—
—
—
0
0
5
22
2.28
1.03
1.2
1.2
—
—
—
0
0
5
22
2.28
1.03
1.2
1.2
—
—
—
0
0
5
22
2.28
1.03
1.8
1.5
—
—
—
0
0
18
115
1.58
1.00
1.1
1.4
0.3
0.4
nmol/l
0.88
13
98
33
240
1.39
1.00
1.4
2.1
—
—
—
0
0
11
61
1.81
0.98
1.1
1.1
—
—
—
0
0
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
16
101
1.60
0.94
1.6
1.6
—
—
—
0
0
12
196
0.61
0.93
2.3
1.7
—
—
—
0
0
118
1023
1.18
0.89
2.2
2.1
—
—
—
0
0
26
186
1.41
0.88
1.3
1.2
—
—
—
0
0
8
44
1.83
0.86
1.1
1.2
—
—
—
0
0
37
478
0.76
0.85
1.4
1.5
—
—
—
0
0
20
137
1.47
0.84
2.8
2.2
78.0
128.2
ug/min
0.38
13
89
29
214
1.37
0.83
1.8
1.7
—
—
—
0
0
141
1255
1.15
0.78
1.6
1.7
414.0
35768215.0
pmol/l
1.77
122
1068
38
297
1.29
0.76
1.4
1.4
—
—
—
0
0
9
53
1.71
0.75
1.1
1.5
1.5
1.4
nmol/l
—
9
46
9
54
1.67
0.74
1.0
1.0
180.2
219.8
mg/l
—
9
43
26
193
1.36
0.74
1.7
1.6
—
—
—
0
0
105
919
1.16
0.73
2.0
1.9
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
25
2.01
0.72
1.6
2.3
182.1
112.8
%
—
5
25
25
185
1.36
0.72
1.3
1.2
—
—
—
0
0
21
151
1.40
0.72
1.1
1.2
4.0
3.8
mmol/l
0.36
21
139
5
26
1.93
0.70
1.0
1.1
100.8
116.4
%
—
5
20
5
26
1.93
0.70
1.0
2.8
—
—
—
0
0
7
41
1.71
0.70
1.6
1.6
—
—
—
0
0
21
281
0.74
0.65
1.5
1.9
—
—
—
0
0
5
29
1.73
0.64
1.0
1.4
183.8
185.3
u/l
—
5
29
13
87
1.50
0.63
2.1
1.5
—
—
—
0
0
22
165
1.34
0.61
1.1
1.3
467.8
419.6
mg/l
0.22
22
153
42
508
0.82
0.60
3.2
2.7
—
—
—
0
0
20
148
1.36
0.60
1.5
1.5
—
—
—
0
0
8
53
1.51
0.58
1.0
1.0
—
—
—
0
0
10
65
1.55
0.55
1.1
1.4
—
—
—
0
0
6
37
1.63
0.55
1.3
1.2
—
—
—
0
0
6
37
1.63
0.55
1.7
1.1
—
1.0
—
0
13
63
544
1.17
0.55
1.2
1.2
151.2
148.3
iu/ml
0.02
23
228
24
186
1.30
0.55
1.2
1.1
—
—
—
0
0
17
125
1.37
0.54
1.5
1.5
—
—
—
0
0
6
40
1.50
0.51
3.0
2.1
645.5
563.3
ml
—
6
23
17
225
0.75
0.51
1.5
1.5
—
—
—
0
0
6
41
1.47
0.50
2.7
1.2
—
—
—
0
0
7
46
1.53
0.48
1.6
1.6
—
—
—
0
0
21
265
0.79
0.46
1.3
1.4
—
—
—
0
0
21
265
0.79
0.46
1.3
1.4
—
—
—
0
0
21
264
0.79
0.45
1.3
1.4
—
—
—
0
0
21
264
0.79
0.45
1.3
1.4
—
—
—
0
0
10
69
1.46
0.44
1.3
1.2
—
—
—
0
0
7
51
1.38
0.44
1.4
1.1
—
2.2
—
0
5
11
78
1.42
0.43
1.1
1.3
—
—
—
0
0
13
96
1.36
0.41
1.1
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
37
323
1.15
0.32
1.4
1.7
4.0
3.2
mg/l
0.27
28
215
17
138
1.24
0.30
1.6
1.5
6111.9
12882.0
e6/l
—
10
96
8
106
0.75
0.29
1.9
3.9
59.0
56.1
%
—
8
106
7
57
1.23
0.29
1.4
1.1
—
94.4
—
0
5
25
288
0.86
0.26
1.4
1.5
—
—
—
0
0
12
96
1.25
0.24
1.3
1.1
—
—
—
0
0
14
115
1.22
0.23
1.3
1.1
—
14.1
—
0
10
5
40
1.25
0.22
1.8
2.7
—
—
—
0
0
35
315
1.12
0.21
1.3
1.6
251.5
325.4
mu/l
1.39
30
283
0
11
0.00
0.21
0.0
2.1
—
0.6
—
0
11
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
5
43
1.16
0.21
1.4
1.4
5.1
5.7
mmol/l
—
5
43
11
89
1.24
0.21
1.1
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
29
324
0.89
0.20
1.6
1.4
—
—
—
0
0
5
69
0.72
0.17
1.0
1.1
—
—
—
0
0
13
114
1.14
0.12
1.3
1.1
—
—
—
0
0
30
279
1.08
0.11
1.1
1.3
221.1
246.3
miu/ml
0.22
16
141
5
44
1.14
0.10
1.2
1.3
—
—
—
0
0
5
45
1.11
0.10
1.0
1.4
—
—
—
0
0
67
696
0.96
0.09
1.5
1.7
—
—
—
0
0
17
155
1.10
0.09
1.2
1.3
—
—
—
0
0
12
134
0.89
0.08
1.8
1.7
—
—
—
0
0
21
196
1.07
0.07
1.5
1.9
1.8
5.0
iu/l
—
5
82
41
396
1.04
0.05
1.5
1.4
—
—
—
0
0
13
126
1.03
0.00
1.0
1.0
1.6
2.5
u/ml
—
6
62
10
102
0.98
0.00
1.2
1.1
—
71.4
—
0
24
0
6
0.00
0.00
0.0
1.2
—
8.0
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
7
79
0.89
0.00
1.1
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
96.6
—
0
9
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_LIVER_EXALLC – Benign neoplasm: Liver
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).